Neogenius Pharma

Neogenius Pharma

Neogenius Pharma The NEOGENIUS Project, set up on the basis of a strategic alliance between three pharmaceutical companies (Almirall, Esteve and Draconis) and a biotech company (Proteomika), received a 7.6 million euros grant from the CENIT programme in 2009. The...
NEOVANC

NEOVANC

NeoVanc – Treatment of late onset bacterial sepsis caused by Vancomycin susceptible bacteria in neonates and infants aged under three months NeoVanc is a project funded by the European Commission under the Seventh Framework Programme, involving 12 partners from...
SAFEGUARD

SAFEGUARD

Safety Evaluation of Adverse Reactions in Diabetes The SAFEGUARD project aims to assess and further quantify and understand the effects of all existing oral blood glucose lowering agents in humans by means of the analysis of anonymised and aggregated data from more...
SEMCARE

SEMCARE

SEMantic Data Platform for HealthCARE SEMCARE aims to build a semantic data platform that is able to identify patient cohorts based on clinical criteria (e.g. age, gender, diagnosis, indication, symptoms, lab results) scattered in heterogeneous clinical resources. The...
SOS

SOS

SOS – Safety Of non-Steroidal anti-inflammatory drugs The SOS project focused on the safety of non-steroidal anti-inflammatory drugs with a specific focus on the evaluation of the gastro-intestinal and cardiovascular effects of traditional NSAIDs and COX-II selective...